Skip to Content

ETF Series Solutions Trust Loncar Cancer Immunotherapy ETF

CNCR
$--
Today’s Change
-- (--)

Snapshot
*

Inception Date
Oct 13 2015
Expense Ratio
0.79%
Type
US Equities
Fund Owner
Exchange Traded Concepts
Volume (1m avg. daily)
$36,772
AUM
$17,052,000
Associated Index
Loncar Cancer Immunotherapy Index
Inverse/Leveraged
No
Passive/Active
Passive
Fractionable on Composer
No
Prospectus

Top 10 Holdings

MRUS
Merus N.V
6.00%
REGN
Regeneron Pharmaceuticals, Inc.
4.53%
BGNE
BeiGene Ltd - ADR
4.35%
RAPT
RAPT Therapeutics Inc
4.17%
XNCR
Xencor Inc
4.16%
MRK
Merck & Co Inc
3.94%
ARGX
Argen X SE - ADR
3.81%
ACLX
Arcellx Inc
3.77%
GILD
Gilead Sciences, Inc.
3.77%
CRSP
CRISPR Therapeutics AG
3.76%
Invest with CNCR

What is CNCR?

The Loncar Cancer Immunotherapy ETF seeks to track the LCINDX index. It is made up of a basket of companies that develop therapies to treat cancer by harnessing the body s own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become the foundational treatment for cancer over the next ten years. A sector ETF focusing on a unique technology like cancer immunotherapy allows investors to focus on interest areas more precisely than broad indices. LCINDX is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.

ETFs related toCNCR

ETFs correlated to CNCR include LABU, XBI, BIB

CNCR
Exchange Traded Concepts Trust - ETCT Loncar Cancer Immunotherapy ETF
LABU
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
XBI
SPDR Series Trust - SPDR Biotech ETF
BIB
ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares
IBB
BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF
ARKG
ARK Investment Management LLC - ARK Genomic Revolution ETF
FBT
First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund
BBH
VanEck ETF Trust - VanEck Biotech ETF
XPH
SPDR Series Trust - SPDR Pharmaceuticals ETF
PSCH
Invesco Capital Management LLC - Invesco S&P SmallCap Health Care ETF
TARK
Investment Managers Series Trust II - AXS 2X Innovation ETF

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

FAQ

CNCR is a US Equities ETF. The Loncar Cancer Immunotherapy ETF seeks to track the LCINDX index. It is made up of a basket of companies that develop therapies to treat cancer by harnessing the body s own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become the foundational treatment for cancer over the next ten years. A sector ETF focusing on a unique technology like cancer immunotherapy allows investors to focus on interest areas more precisely than broad indices. LCINDX is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.

CNCR tracks the Loncar Cancer Immunotherapy Index.

No, CNCR is not actively managed. It is passively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

Yes, CNCR is passively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on CNCR is -0.1318%. This is the percent change in the value of CNCR over the most recent 1-month period. The 3-month return on CNCR is -0.1544%. This is the percent change in the value of CNCR over the most recent 3-month period.

The standard deviation of CNCR for the past year is 0.389%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to CNCR include XLI, XLE, and XLP.

ETFs correlated to CNCR include LABU, XBI, and BIB.

ETFs that are inversely correlated to CNCR include LABD, SARK, and SRTY.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.